Serizawa M - Search Results

1

High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.

Yoshimura A, Yamada T, Serizawa M, Uehara H, Tanimura K, Okuma Y, Fukuda A, Watanabe S, Nishioka N, Takeda T, Chihara Y, Takemoto S, Harada T, Hiranuma O, Shirai Y, Shukuya T, Nishiyama A, Goto Y, Shiotsu S, Kunimasa K, Morimoto K, Katayama Y, Suda K, Mitsudomi T, Yano S, Kenmotsu H, Takahashi T, Takayama K. Yoshimura A, et al. Among authors: serizawa m. Cancer Sci. 2023 Feb;114(2):606-618. doi: 10.1111/cas.15608. Epub 2022 Nov 11. Cancer Sci. 2023. PMID: 36169649 Free PMC article.

2

MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.

Kaira K, Murakami H, Serizawa M, Koh Y, Abe M, Ohde Y, Takahashi T, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: serizawa m. Virchows Arch. 2011 May;458(5):615-20. doi: 10.1007/s00428-011-1041-x. Epub 2011 Jan 21. Virchows Arch. 2011. PMID: 21253760

3

Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.

Kaira K, Serizawa M, Koh Y, Takahashi T, Hanaoka H, Oriuchi N, Endo M, Kondo H, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: serizawa m. Eur J Cancer. 2012 May;48(8):1244-54. doi: 10.1016/j.ejca.2012.01.016. Epub 2012 Feb 11. Eur J Cancer. 2012. PMID: 22330319

4

The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapy.

Akamatsu H, Kaira K, Murakami H, Serizawa M, Koh Y, Ono A, Shukuya T, Tsuya A, Nakamura Y, Kenmotsu H, Naito T, Takahashi T, Endo M, Harada H, Nakajima T, Yamamoto N. Akamatsu H, et al. Among authors: serizawa m. Am J Clin Oncol. 2014 Apr;37(2):144-7. doi: 10.1097/COC.0b013e31826e04f9. Am J Clin Oncol. 2014. PMID: 23211219

5

Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cells.

Serizawa M, Takahashi T, Yamamoto N, Koh Y. Serizawa M, et al. J Thorac Oncol. 2013 Mar;8(3):259-69. doi: 10.1097/JTO.0b013e318279e942. J Thorac Oncol. 2013. PMID: 23334091 Free article.

6

Genomic aberrations associated with erlotinib resistance in non-small cell lung cancer cells.

Serizawa M, Takahashi T, Yamamoto N, Koh Y. Serizawa M, et al. Anticancer Res. 2013 Dec;33(12):5223-33. Anticancer Res. 2013. PMID: 24324054

7

Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.

Kaira K, Serizawa M, Koh Y, Takahashi T, Yamaguchi A, Hanaoka H, Oriuchi N, Endo M, Ohde Y, Nakajima T, Yamamoto N. Kaira K, et al. Among authors: serizawa m. Lung Cancer. 2014 Feb;83(2):197-204. doi: 10.1016/j.lungcan.2013.11.025. Epub 2013 Dec 7. Lung Cancer. 2014. PMID: 24365102

8

Molecular profiling of small cell lung cancer in a Japanese cohort.

Wakuda K, Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi S, Ono A, Taira T, Naito T, Murakami H, Mori K, Endo M, Nakajima T, Ohde Y, Takahashi T, Yamamoto N. Wakuda K, et al. Among authors: serizawa m. Lung Cancer. 2014 May;84(2):139-44. doi: 10.1016/j.lungcan.2014.02.013. Epub 2014 Mar 3. Lung Cancer. 2014. PMID: 24657128

9

Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells.

Serizawa M, Murakami H, Watanabe M, Takahashi T, Yamamoto N, Koh Y. Serizawa M, et al. Cancer Sci. 2014 Jun;105(6):683-9. doi: 10.1111/cas.12411. Epub 2014 May 10. Cancer Sci. 2014. PMID: 24698130 Free PMC article.

10

Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study.

Serizawa M, Koh Y, Kenmotsu H, Isaka M, Murakami H, Akamatsu H, Mori K, Abe M, Hayashi I, Taira T, Maniwa T, Takahashi T, Endo M, Nakajima T, Ohde Y, Yamamoto N. Serizawa M, et al. Cancer. 2014 May 15;120(10):1471-81. doi: 10.1002/cncr.28604. Epub 2014 Apr 3. Cancer. 2014. PMID: 24700479 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page